Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 10 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLCRecruitingNCT06552234Phase 2
- Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRIRecruitingNCT06545747Phase 3
- Study of XB010 in Subjects With Solid TumorsRecruitingNCT06545331Phase 1
- Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary OligometastasesRecruitingNCT06542159Phase 2
- The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung CancerRecruitingNCT06540196Not applicable
- TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung CancerRecruitingNCT06538012Phase 1/2
- Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal MetastasesNot yet recruitingNCT06537297Phase 2
- Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction TreatmentRecruitingNCT06534489
- A Study to Evaluate the Efficacy of Osimertinib in Patients With EGFR-sensitive Mutated Non-small Cell Lung Cancer Progression After Receiving Adjuvant Targeted Therapy Following Radical SurgeryNot yet recruitingNCT06530719Phase 2
- Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseRecruitingNCT06529822Phase 1
- Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung AdenocarcinomaRecruitingNCT06528847Phase 2
- Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMERRecruitingNCT06528743Not applicable
- SMP-3124LP in Adults With Advanced Solid TumorsRecruitingNCT06526819Phase 1/2
- A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerNot yet recruitingNCT06525350Phase 2
- Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung CancerRecruitingNCT06523673Phase 3
- Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung CancerRecruitingNCT06518057Phase 2
- Befotertinib and Icotinib for NSCLC With Uncommon EGFR MutationsRecruitingNCT06517953Phase 2
- A Study of DM005 in Patients With Advanced Solid TumorsRecruitingNCT06515990Phase 1/2
- Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion MutationsRecruitingNCT06514027Phase 2
- A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung CancerRecruitingNCT06512207Not applicable
- A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung CancerRecruitingNCT06512051Phase 1/2
- A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLCNot yet recruitingNCT06503042
- Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialRecruitingNCT06500481Phase 3
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialRecruitingNCT06498635Phase 3
- Segmentectomy After Induction Therapy (SAINT)RecruitingNCT06496659Not applicable
- A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene AbnormalityRecruitingNCT06496490Phase 2
- Prediction of Mediastinal Station IV Lymph Node Metastasis in Non-small Cell Lung CancerRecruitingNCT06496360
- The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC PatientsNot yet recruitingNCT06496009
- NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic AlterationsRecruitingNCT06494540
- Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.RecruitingNCT06492421Phase 2
- EGFR-mutated Lung Cancer in Randomized Investigator-Initiated StudyRecruitingNCT06486142Phase 3
- A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLCNot yet recruitingNCT06485557Phase 3
- IMPT Dose Escalation for NSCLC (HyDose)RecruitingNCT06484491Not applicable
- Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLCNot yet recruitingNCT06483009Phase 4
- Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer PatientsRecruitingNCT06481813Not applicable
- Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical TrialRecruitingNCT06481566Not applicable
- SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line TreatmentNot yet recruitingNCT06480136Phase 2
- LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT06479759Phase 2
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.RecruitingNCT06476808Phase 1
- SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung CancerRecruitingNCT06476093Not applicable
- Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLCNot yet recruitingNCT06475755Phase 2
- A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsRecruitingNCT06475300Phase 2
- A Phase Ib Study of GC101 in NSCLCRecruitingNCT06473961Phase 1
- Insomnia in Patients With Metastatic Lung CancerRecruitingNCT06472804
- Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorRecruitingNCT06472245Phase 3
- Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLCRecruitingNCT06467617Phase 2
- A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed ImmunotherapyRecruitingNCT06467500Phase 2
- A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally AdvancedRecruitingNCT06467383
- Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLCNot yet recruitingNCT06465238Phase 2
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsRecruitingNCT06465069Phase 1
- Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerRecruitingNCT06463665Phase 2
- Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung CancerNot yet recruitingNCT06463171Phase 2
- A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)RecruitingNCT06461156Phase 1
- TIL Therapy in Non-small-cell Lung Cancer (NSCLC) PatientsRecruitingNCT06455917Phase 2
- Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06454890Phase 1/2
- Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.Not yet recruitingNCT06452433Phase 2
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsRecruitingNCT06451497Phase 1
- Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk FeaturesRecruitingNCT06449313Phase 2
- EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.RecruitingNCT06448572Phase 1/2
- Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC TreatmentRecruitingNCT06445881Phase 2
- A Study of VET3-TGI in Patients With Solid TumorsRecruitingNCT06444815Phase 1
- Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal MetastasesRecruitingNCT06440954Phase 2
- First-in-human Study of Interferon-y PET Imaging to Assess Response to ImmunotherapyRecruitingNCT06439914Phase 1
- Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)RecruitingNCT06437977Phase 3
- An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung CancerRecruitingNCT06436885Early Phase 1
- Outpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving ImmunotherapyRecruitingNCT06436625Not applicable
- Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLCNot yet recruitingNCT06436144Phase 2
- A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLCNot yet recruitingNCT06434740Phase 2
- Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.RecruitingNCT06431633Phase 3
- The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer PatientsRecruitingNCT06428422Not applicable
- ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLCRecruitingNCT06426511Phase 2
- A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLCRecruitingNCT06424899Phase 2
- Phase 2 Study of Fingolimod in Lung CancersRecruitingNCT06424067Phase 2
- A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLCRecruitingNCT06422546
- Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]RecruitingNCT06422143Phase 3
- A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLCRecruitingNCT06418412
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruitingNCT06418204
- A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung CancerRecruitingNCT06417008Phase 2/3
- Clinical Study of 18F-Alfatide Injection PET/CTNot yet recruitingNCT06416852Phase 3
- A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC PatientsRecruitingNCT06412471Phase 2
- Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung CancerRecruitingNCT06406608Not applicable
- Lifei Xiaoji Wan in Treatment of Advanced NSCLCRecruitingNCT06406166Not applicable
- FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLCRecruitingNCT06403111Phase 2
- A Study of Sofe-M in Participants With Selected Advanced Solid TumorsRecruitingNCT06400472Phase 1
- High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With OsimertinibRecruitingNCT06394674Phase 2
- Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung CancerNot yet recruitingNCT06394427
- Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung CancerNot yet recruitingNCT06391008Phase 2
- ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICIRecruitingNCT06388031Phase 2
- A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D MutationRecruitingNCT06385925Phase 1/2
- TOP 2301: Neoadjuvant Chemo for NSCLCRecruitingNCT06385262Phase 2
- A Phase I/II Trial of UCB4594 in Participants With Advanced CancerRecruitingNCT06380816Phase 1/2
- JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins MutationsNot yet recruitingNCT06380348Phase 3
- Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLCRecruitingNCT06379087Phase 2
- A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on LorlatinibRecruitingNCT06378892Phase 2
- Exercise in Patients With Advanced Non-small Cell Lung CancerNot yet recruitingNCT06374160Not applicable
- the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With TrilaciclibEnrolling by invitationNCT06370416Phase 2
- Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLCRecruitingNCT06369181
- DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLCRecruitingNCT06364917Phase 2
- Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II TrialRecruitingNCT06363734Phase 2
- A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR MutationsRecruitingNCT06362980Phase 1